Evidence map›Paper›PMID 40754880›Full record

ArticleCurrent drug delivery2025

Advancements in Nanocarrier Production Techniques and Methods for Enhanced Targeted Delivery of Drug: A Comprehensive Review.

Atish Kumar S Mundada, Lokesh P Kothari, Kuldeep Vinchurkar, Saloni Yadav, Arprita Malhan, Mridul Guleria, Sudarshan Singh

Abstract read
In one paragraph

Article in Current drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Atish Kumar S MundadaDepartment of Pharmaceutics, SNJBs SSDJ College of Pharmacy, Chandwad, Nashik, Maharashtra 423101, India.
Lokesh P KothariDepartment of Pharmaceutics, SNJBs SSDJ College of Pharmacy, Chandwad, Nashik, Maharashtra 423101, India.
Kuldeep VinchurkarDepartment of Pharmaceutics and Pharmaceutical Technology, Krishna School of Pharmacy and Research (BITS Edu Campus), Dr. Kiran and Pallavi Patel Global University, Vadodara, Gujarat 391240, India.
Saloni YadavAcropolis Institute of Pharmaceutical Education and Research, Indore, Madhya Pradesh 453771, India.
Arprita MalhanDepartment of Pharmaceutical Science, Guru Nanak Dev University, Amritsar, Punjab 143005, India.
Mridul GuleriaDepartment of Pharmaceutical Science, Guru Nanak Dev University, Amritsar, Punjab 143005, India.
Sudarshan SinghFaculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology has transformed drug delivery systems, leading to the creation of various nanocarriers that offer significant advantages over traditional methods. This review explores key techniques and methods for producing nanocarriers like liposomes, niosomes, dendrimers, nanocapsules, carbon nanotubes, polymeric micelles, and solid lipid nanoparticles. Operating within the nanoscale range (1-100 nm), these nanocarriers enhance drug efficacy, reduce side effects, and improve bioavailability. Liposomes are generated using methods, such as the Bangham procedure, solvent injection, and microfluidic channels. Nanocarriers have become fundamental to sophisticated drug delivery systems, providing improved precision, regulated release, and targeted therapeutic administration. Innovative methods, such as microfluidics and nanoprecipitation, have enhanced the scalability and consistency of nanocarriers, while progress in surface engineering, including ligand conjugation and stimuli-responsive coatings, facilitates improved targeting and controlled drug release. The advancement of biocompatible and biodegradable nanomaterials, including polymeric nanoparticles, liposomes, and dendrimers, has broadened the clinical utility of nanocarriers, especially in oncology, neurology, and gene therapy. This review underscores the versatility and potential of these nanocarriers in advancing drug delivery, emphasizing their capacity for targeted, efficient, and controlled therapeutic interventions.

Indexed as

LiposomesNano capsulesNanocarriersNanotechnologyNiosomesTechniques for producing nanocarriers.

Identifiers

PMID40754880
PMCPMC13684979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.